We compared the expression of immune cell markers, including CD19, CD4, CD8A, FOXP3, ITGAX, CD68, and CD163, in the sections between DCIS and IDC areas (Fig 6B). The gene discussed is ITGAX; the disease is ductal breast carcinoma in situ.